JPRN-UMIN000002324
Completed
未知
biomarker study of the effect and adverse event for neoadjuvantchemotherapy with breast cancer patinets - biomarker study for breast cancer neoadjuvant chemotherapy
Conditionsbreast cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- breast cancer
- Sponsor
- national cancer center
- Enrollment
- 180
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Exploration of biomarkers to predict the effects of anti TSLP antibody (Tezepelumab) in refractory asthma patients using comprehensive analyses of changes in gene expression in whole blood cellsSevere asthmaJPRN-UMIN000050670Department of Respiratory Medicine, University of Tsukuba50
Not yet recruiting
Phase 2
An Observational Study To Relate Two Biological markers with Left Heart Pressure And Blood Concentration of A Drug Dobutamine In Patients Undergoing By Pass Heart SurgeryCTRI/2018/05/013554R SUBHASHINI
Active, not recruiting
Phase 1
Biomarkers Impact On the response to Treatment with Erlotinibon-small cell lung cancerEUCTR2009-017063-42-RORoche Romania SR
Active, not recruiting
Phase 1
The value of blood measurements, ultrasound an muscle electric studies to fortell the outcome of low back pain and sciatic pain and to evaluate the effect of the muscle relaxant tolperisoEUCTR2019-001885-14-HUational Research, Development and Innovation Office150
Active, not recruiting
Phase 1
Biomarkermoderate-to-severe psoriasisMedDRA version: 19.0 Level: PT Classification code 10037153 Term: Psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2015-002588-40-DEniversity Hospital Schleswig-Holstein40